EW Edwards Lifesciences Earnings and EPS analysis

EPS in 2025 (TTM): $6.99

Last Report Period Date: Jun 30, 2025

As of November 2025, according to Edwards Lifesciences's latest financial report, the company's current EPS (TTM) is $6.99. Edwards Lifesciences's EPS for 2024 came in at $6.98, marking an increase from $2.31 in 2023. Edwards Lifesciences's earnings per share for the quarterly report ending on Jun 30, 2025 was $0.57.

The annual EPS in 2024 was $6.98, an increase of 202.2% from $2.31 in 2023. The quarterly EPS for the period ending Jun 30, 2025, was $0.57, marking a 6.6% decrease from the same quarter last year. EW's TTM EPS stands at $6.99 as of June 2025. Edwards Lifesciences's EPS for 2023 stood at $2.31, a 6.1% decrease from 2022.

Edwards Lifesciences has recorded a decrease in EPS of 6.6% over the last 12 months (YoY, quarterly). For the last three years, EW recorded an average annual EPS growth rate of 42.5%. Edwards Lifesciences had an average annual EPS growth rate of 33% over the last 5 years. Across the last decade, EW had an average annual EPS growth of 18.6%.